Micro Emerging Active

BMRN stock rated overweight despite Voxzogo Phase 2 study discontinuations

New narrative with limited coverage — still forming.

Score
0.2
Velocity
▲ 0.0
Articles
2
Sources
1

Sentiment Timeline

Event Timeline

Mar 31, 2026
B. Riley Lifts PT on Bitmine Immersion Technologies (BMNR) to $33 From … Bullish
Mar 30, 2026
BioMarin Pharmaceutical Inc. (BMRN) Rated Overweight at Wells Fargo Despite Voxzogo Phase … Neutral

Timeline

First SeenMar 30, 2026
Last UpdatedMar 30, 2026